MedPath

NEW AMMELTZ

NEW AMMELTZ

Approved
DIN Number

02322714

Drug Class

Human

Market Date

N/A

Company
HC

classical remedia ltd

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02322714
AIG Number0252534001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
M02AC PREPARATIONS WITH SALICYLIC ACID DERIVATIVES
Product Specifications
Dosage FormLiquid
Route of AdministrationTopical
AHFS Classification28:08.04.24
Health Canada Classification

ACTIVE INGREDIENTS (2)

GLYCOL SALICYLATEActive
Strength: 25 MG / ML
Monograph: GLYCOL SALICYLATE
LEVOMENTHOLActive
Strength: 30 MG / ML
Monograph: LEVOMENTHOL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.